Press Release

Back to Press Release List

AACR Poster Presentation: “KSQ-001: A CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTIL™) Therapy for Solid Tumors

Click image to enlarge.

Click to download PDF file.

© 2022 KSQ Therapeutics, Inc. All rights reserved.